GekkoVet and Royal Canin Take Veterinary Decision Support Global After 92% Pilot Success
8.9.2025 15:30:00 CEST | Business Wire | Press Release
GekkoVet, a leader in AI‑powered clinical decision support for veterinarians, and Royal Canin, a global leader in Health Through Nutrition for cats and dogs, are expanding their strategic collaboration worldwide after a pilot program in which 92% of veterinarians who used GekkoVet agreed it increased efficiency and had a positive impact on clinic’s revenue.
The platform’s four integrated features — Diagnosing Assistance, Disease & Treatment Library, Drug Library, and Drug Calculator — are now set to reach veterinary professionals across the globe, helping them make faster, evidence‑based decisions that improve patient care and clinic performance.
Royal Canin’s decision to scale the offering follows overwhelmingly positive feedback from pilot participants. One veterinarian noted, “GekkoVet increased efficiency and had a positive impact on my clinic's revenue while helping me to have better patient outcomes.”
Key Facts
- 92% success rate among pilot participants
- Four tools in one: Symptom Checker, Disease & Treatment Library, Drug Library, Drug Calculator
- Global rollout starting Q4 2025, expansion to all markets in 2026
- Proven impact: Increased diagnostic confidence, efficiency, clinic revenue
Quotes
- “This collaboration reflects our shared vision of supporting veterinarians with intelligent tools that enhance clinical decision-making and elevate the standard of care,” — Dr. Johanna Majamaa, CEO, GekkoVet
- “At Royal Canin, we believe in empowering veterinary teams with the best tools available. GekkoVet’s platform aligns perfectly with our mission to advance pet health through science and partnership. We’re excited to bring this solution to more clinics to achieve our Purpose: A BETTER WORLD FOR PETS” — Dr. Brent Mayabb, Global Chief Medical Officer, Royal Canin
About GekkoVet
GekkoVet is a Finnish health tech company providing AI-powered clinical decision support tools for veterinary professionals. Trusted by thousands of clinics worldwide, GekkoVet helps veterinarians make faster, more accurate diagnoses and improve patient care.
About ROYAL CANIN®:
ROYAL CANIN® is part of the Royal Canin Division in the Mars, Incorporated group, and a global leader in Health Through Nutrition for cats and dogs fulfilling its Purpose: A BETTER WORLD FOR PETS. Founded in 1968 by French veterinarian, Dr. Jean Cathary, ROYAL CANIN® designs precise, science-based nutrition for cats and dogs available at pet specialty retailers and veterinary practices worldwide.
Over the years, ROYAL CANIN® has pushed the limits of nutrition and knowledge in partnership with pet professionals, including breeders and veterinarians.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250908542859/en/
Contacts
CEO Johanna Majamaa, DVM
+358451896144
johanna.majamaa@gekkovet.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma’s Relfydess™ (relabotulinumtoxinA) Receives Approval in China for Frown Lines23.10.2026 07:00:00 CEST | Press Release
Galderma (SIX: GALD) today announced that the Chinese NMPA has approved Relfydess for the temporary improvement of moderate-to-severe frown lines in adults, marking a significant expansion of the company’s Injectable Aesthetics portfolio in China – one of the world's largest and fastest-growing aesthetics markets.8,9 This approval follows successful authorizations and launches of Relfydess in more than 35 markets worldwide. Relfydess is the first and only ready-to-use liquid neuromodulator developed with PEARL Technology, designed to deliver a highly active, innovative, complex-free molecule that addresses the real needs of patients and healthcare professionals.1,2,4,5 It is optimized for simple volumetric dosing, without reconstitution, to increase ease-of-use and help ensure consistent dose/volume every time.1,10 At a time whenpatients and healthcare professionals are increasingly seeking high-performance neuromodulators that rapidly deliver long-lasting, natural-looking outcomes, Re
Mundipharma Announces Further Phase III ReSPECT Results Presented as a Late-Breaking Oral Presentation at IDWeek 202622.10.2026 19:03:00 CEST | Press Release
Today Mundipharma announced additional results from the global Phase III ReSPECT clinical trial evaluating REZZAYO®(rezafungin acetate) for prophylaxis of invasive fungal diseases (IFDs) in adult patients undergoing allogeneic haematopoietic stem cell transplantation (allo-HSCT). The Phase III findings were presented today as a late-breaking oral presentation at IDWeek 2026. The presentation provides additional detail following the top line ReSPECT results announced in April 2026, including further endpoint analyses, the components contributing to fungal-free survival (FFS), pre-specified sensitivity analyses and detailed safety outcomes. The additional analyses were consistent with the previously announced topline findings. ReSPECT was a global, multicentre, randomised, double-blind Phase III study in which 402 patients were randomised to rezafungin and 200 to the standard antimicrobial regimen. As previously announced, the study met its primary endpoint, demonstrating non-inferiority
Tigo Energy Improves Installer Choice via Fronius Compatibility with TS4 Product Line22.10.2026 18:02:00 CEST | Press Release
Tigo Energy, Inc. (NASDAQ: TYGO) (“Tigo” or “Company”), a leading provider of intelligent solar and energy software solutions, today announced a manufacturer declaration of compatibility from Fronius International GmbH, documenting compatibility between Tigo Flex MLPE products and multiple Fronius inverter families. The letter covers Tigo TS4-A-F, TS4-A-2F, TS4-A-O, and TS4-X-O products and the Fronius Primo GEN24, Primo GEN24 208-240, Symo GEN24, Verto, Tauro, and Tauro ECO inverter families, when configured according to the requirements specified by Fronius and Tigo. Building on established compatibility in Europe, the declaration extends manufacturer-confirmed compatibility to markets worldwide, including the United States and Canada, giving solar professionals greater flexibility to design high-quality systems using manufacturer-confirmed technology combinations. Fronius develops solar technologies and solutions for residential, commercial, and large-scale applications, with a port
Saudi Maritime & Logistics Congress Highlights Maritime Sector Integration and Opportunities for Trade and Investment Growth in the Kingdom22.10.2026 16:52:00 CEST | Press Release
The Saudi Maritime & Logistics Congress highlighted Saudi Arabia’s role in supporting the continuity of trade flows and strengthening supply chain resilience as it opened at Jeddah Superdome, bringing together representatives of government entities, maritime transport and logistics leaders, and the business community. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261022362613/en/ The Congress takes place as rapid changes in trade and shipping prompt companies to reassess transport routes and operational and investment choices. It provides a platform for dialogue among stakeholders to explore opportunities for cooperation and strengthen integration between ports and maritime, land transport and logistics services, supporting operational efficiency and supply chain reliability. In his opening address, His Excellency Eng. Fawaz Alsahli, President of the Transport General Authority in Saudi Arabia, emphasised that the Kingdom’s
Ministerial Roundtable Discusses Mobilising Green Investments for a Resilient and Inclusive Global Economy22.10.2026 16:49:00 CEST | Press Release
HE Saeed Mohammed Al Tayer, Chairman of the World Green Economy Organization, opened the Ministerial Roundtable titled "From Ambition to Bankable Action-Mobilising Green Investments for a Resilient and Inclusive Global Economy," during the 12th World Green Economy Summit (WGES), held on 21-22 October 2026 at the Dubai World Trade Centre under the theme "From Success to Scale: Showcasing the Green Economy." This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261022803264/en/ Ministerial Roundtable Discusses Mobilising Green Investments for a Resilient and Inclusive Global Economy (Photo: AETOSWire) The session was attended by HE Dr. Amna bint Abdullah Al Dahak, Minister of Climate Change and Environment, the United Arab Emirates; HE Aliou Gori Diouf, Minister of Environment and Ecological Transition, Senegal; HE Balarabe Abbas Lawal, Minister of Environment, Nigeria; HE Steven Victor, Minister of Agriculture, Fisheries, and the En
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom